126 related articles for article (PubMed ID: 37933030)
21. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
22. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.
Kim HM; Lee YK; Koo JS
Dis Markers; 2016; 2016():4218989. PubMed ID: 27881889
[No Abstract] [Full Text] [Related]
23. ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor.
Munawer NH; Md Zin R; Md Ali SA; Muhammad R; Ali J; Das S
Biomed J; 2012; 35(6):486-92. PubMed ID: 23442362
[TBL] [Abstract][Full Text] [Related]
24. Phyllodes tumor of the breast. A cytohistologic study of 80 cases.
Bhattarai S; Kapila K; Verma K
Acta Cytol; 2000; 44(5):790-6. PubMed ID: 11015981
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.
Shpitz B; Bomstein Y; Sternberg A; Klein E; Tiomkin V; Kaufman A; Groisman G; Bernheim J
J Surg Oncol; 2002 Feb; 79(2):86-92. PubMed ID: 11815995
[TBL] [Abstract][Full Text] [Related]
26. Fibroadenoma versus phyllodes tumor: a vexing problem revisited!
Tummidi S; Kothari K; Agnihotri M; Naik L; Sood P
BMC Cancer; 2020 Jul; 20(1):648. PubMed ID: 32660435
[TBL] [Abstract][Full Text] [Related]
27. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
28. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
29. Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: proposal fibroadenoma, cellular variant.
Hasebe T; Imoto S; Sasaki S; Tsubono Y; Mukai K
Pathol Int; 1999 May; 49(5):435-43. PubMed ID: 10417687
[TBL] [Abstract][Full Text] [Related]
30. Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis.
Lu Y; Chen Y; Zhu L; Cartwright P; Song E; Jacobs L; Chen K
Ann Surg Oncol; 2019 May; 26(5):1263-1275. PubMed ID: 30617873
[TBL] [Abstract][Full Text] [Related]
31. Survey of recurrent diagnostic challenges in breast phyllodes tumours.
Tan BY; Fox SB; Lakhani SR; Tan PH
Histopathology; 2023 Jan; 82(1):95-105. PubMed ID: 36468287
[TBL] [Abstract][Full Text] [Related]
32. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
[TBL] [Abstract][Full Text] [Related]
33. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
[TBL] [Abstract][Full Text] [Related]
34. Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.
Kucuk U; Bayol U; Pala EE; Cumurcu S
Indian J Pathol Microbiol; 2013; 56(2):129-34. PubMed ID: 24056649
[TBL] [Abstract][Full Text] [Related]
35. Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth.
Guerrero MA; Ballard BR; Grau AM
Surg Oncol; 2003 Jul; 12(1):27-37. PubMed ID: 12689668
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of breast phyllodes tumors.
Shin E; Koo JS
Histol Histopathol; 2023 Aug; 38(8):865-878. PubMed ID: 36866915
[TBL] [Abstract][Full Text] [Related]
37. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
[TBL] [Abstract][Full Text] [Related]
38. Recurrence prediction for breast phyllodes tumours: validation of the Singapore nomogram in Korean women.
Choi JE; Kang SH; Tan PH; Bae YK
J Clin Pathol; 2022 Mar; 75(3):159-163. PubMed ID: 33376198
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast.
Barrio AV; Clark BD; Goldberg JI; Hoque LW; Bernik SF; Flynn LW; Susnik B; Giri D; Polo K; Patil S; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2961-70. PubMed ID: 17562113
[TBL] [Abstract][Full Text] [Related]
40. [Histologic classification and prognosis factors in phyllodes tumors of breast].
Jia C; Mei F; Liu JY; Zhao HM; Lei YT; Su J; Huang SS; Zheng J; You JF
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):14-19. PubMed ID: 28072970
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
